GREAT POINT PARTNERS LLC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 90 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
GREAT POINT PARTNERS LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2019$2,958,000
-99.9%
3,500,0000.0%0.27%
-28.2%
Q2 2019$3,416,000,000
+77360.3%
3,500,0000.0%0.38%
-13.1%
Q1 2019$4,410,000
-55.3%
3,500,000
+14.9%
0.44%
-65.0%
Q4 2018$9,867,0003,045,4231.25%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q4 2018
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders